OncoDaily Newsletter

Subscribe to our newsletter

Subscribe

FDA Rare Disease Endpoint Advancement Pilot Program Accepting Applications Through June 30, 2026

Muna Al-Khaifi: Translating Evidence Into Everyday Practice for Cancer-Related Fatigue

Andy Whitfield’s Final Battle: The Spartacus Star and Stage IV Non-Hodgkin Lymphoma

Christopher Conn: Honored to Step Into the Role of Global Head of Diagnostics at Amgen

Gustavo Monnerat: 2 Blinded Clinicians. 6 AI Systems. 100 Real Patient Questions

Oncology News, Insights, Stories by OncoDaily

ESMO TAT 2026- OncoDaily
Not To Miss

15 Posts Not to Miss from ESMO TAT Asia 2026

Screening - OncoDaily
New Paper Alert

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

STAMP Inhibitors Against CML: Prof. Timothy Hughes
Dialogues

STAMP Inhibitors Against CML: Prof. Timothy Hughes

EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer

Global AYA ALL Status - Resonance

Remembering Phuong Ly-Gallagher: The Advocate Who Never Stopped Showing Up

Prof. Claire Harrison Honored with 2026 EHA Lifetime Achievement Award

INAVO120 Safety Analysis Shows Manageable Profile of Inavolisib Plus Palbociclib–Fulvestrant in PIK3CA-Mutated Advanced Breast Cancer

MonumenTAL-3 Supports Tal-D With or Without Pom as a New Standard of Care in 2L RRMM

Hesham ElGhazaly: Celebrating 60 Years of Translating Science Into Impactful Policy at IARC

Voices
Raffaele Colombo

Raffaele Colombo: A Portuguese Real-World Study in Patients With HER2-low Breast Cancer

Herbert Loong: Looking Forward to Seeing My Australian Colleagues Sydney November at COSA26

Fredrik Schjesvold: Cilta-cel, Bela-pomdex and Elo-pomdex Approved on the Same Day in Norway!

Celebrating Roy Herbst’s 15 Years of Leadership at Yale Cancer Center

Board of Directors Applications Now Open for City Cancer Challenge

Oliver Bogler: Most of the Time, the Comparison Falls Apart the Moment You Take It Seriously

Tanja Obradovic: ASCO2026 and What Are Shifts in Development Strategy and Business Focus?

FDA Approvals
Decnupaz

FDA Approved Decnupaz (pivekimab sunirine-pvzy), the First ADC for Adults With BPDCN

FDA Approves FoundationOne CDx as Companion Diagnostic for TEPMETKO in METex14 NSCLC

FDA approved Atezolizumab for adjuvant treatment of MDR–positive MIBC

FDA Grants Approval for Oral Decitabine/Cedazuridine With Venetoclax in Newly Diagnosed AML

FDA Greenlit New Pancreatic Cancer Drug Daraxonrasib For Expanded Access

FDA Grants Full Approval of Tecartus for Relapsed/Refractory Mantle Cell Lymphoma in Adults

FDA Grants Fast Track Designation to TRI-611 in ALK-Positive NSCLC

OncoDaily 100
100 Xfluencers in Prostate Cancer

100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2025

The 100 Most Influential CEOs in Oncology in 2025 (Full List)

The 100 Most Influential People in Oncology in 2025 (Full List)

100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2025

100 Influential Women in Oncology: Key Opinion Leaders to follow on Social Media in 2024

Top 100 Xfluencers in Lung Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Top 100 Xfluencers in Breast Cancer: Key Opinion Leaders to Follow on X (Twitter) in 2024

Celebrities and Cancer

OncoCalendar

2026 Summit for Novel Therapeutics in Oncology and Precision Medicine in Cancer (STOP Cancer)

Horizon CME

07 Aug
Precision Medicine

Shift: AI and Mental Health Innovations in Oncology

17 Jun
Mental Health

Australian and New Zealand Society of Palliative Medicine Conference (ANZSPM 2026)

Australian and New Zealand Society of Palliative Medicine

24 Sep
Palliative Medicine

22nd Biennial Meeting of the European Society for Immunodeficiencies (ESID 2026)

KENES Group

14 Oct
ESID 2026

13th International Paediatric Renal Tumours Biology Conference, London, 11-13th October 2026

International Society of Paediatric Oncology (SIOP)

11 Oct
Renal Tumours

Immune-oncology
Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma

Atezolizumab Plus Bevacizumab in Child-Pugh B Hepatocellular Carcinoma

OCEANUS Study: Combination of Radiotherapy and Immunotherapy in Advanced NSCLC

Sipuleucel-T With or Without IL-7 in mCRPC: FDG PET/CT Offers Early Imaging Insights

Immunotherapy in Head and Neck Cancer

10 Immunotherapy Posts Not To Miss From ASCO 2026

Immunotherapy for Early-Stage Cutaneous Squamous Cell Carcinoma

AI-Based Histopathology Analysis Predicts Checkpoint Inhibitor Response in Advanced Melanoma

Gastrointestinal-Oncology
Fostrox and Lenvatinib

Fostrox Plus Lenvatinib Shows Encouraging Activity as Second-Line Therapy in Advanced Hepatocellular Carcinoma

10 Must-Read Posts In GI Oncology This Week

OCLURANDOM: [177Lu]Lu-dota-tate Shows Antitumor Activity in Progressive Metastatic Pancreatic Neuroendocrine Tumors

10 Must-Read Posts In GI Oncology This Week

Vopimetostat Plus Daraxonrasib Shows 92% ORR in MTAP-Deleted, RAS-Mutant mPDAC

PRODIGE 61–FUNGEMAX: Sequential Chemotherapy in First-Line Metastatic Pancreatic Cancer

TESAR Trial: Adjuvant ChemoRT vs Completion TME After Local Excision for Early Rectal Cancer

Breast-Oncology
EMBER-3 PRO

EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer

Early ctDNA Dynamics Predict Outcomes in Advanced ER-Positive/HER2-Negative Breast Cancer

Serial ctDNA Kinetics May Help Predict Outcomes in Metastatic Breast Cancer

INAVO120 Safety Analysis Shows Manageable Profile of Inavolisib Plus Palbociclib–Fulvestrant in PIK3CA-Mutated Advanced Breast Cancer

Anbenitamab Plus HB1801 Meets Phase III Endpoint in First-Line HER2-Positive Advanced Breast Cancer

BEGONIA Arm 6: Durvalumab Plus T-DXd Shows Activity in HER2-Low Breast Cancer

Carboplatin Improves Event-Free Survival in Early Triple-Negative Breast Cancer: Results From PEARLY Trial

Lung-Oncology
Treatment-Free Survival

Treatment-Free Survival in NSCLC: 2-Year ICI Completion Shows Durable Benefit

Improving Lung Cancer Screening Diagnostic Efficiency: Balancing Early Detection and Avoiding Harm

KRAS Q61-Mutant NSCLC Shows Distinct Molecular Patterns and Better Outcomes With Immunotherapy-Based Regimens

Nivolumab Plus Ipilimumab With Chemotherapy Shows Long-Term OS Advantage in PD-L1-Negative Advanced NSCLC

ASCO Living Guideline 2026.3.0 Updates Treatment Roadmap for Stage IV NSCLC With Driver Alterations

Early ctDNA May Stratify Survival In Locally Advanced And Oligometastatic NSCLC Treated With Radiotherapy

High PD-L1 Expression Linked To Shorter PFS With First-Line ALK TKIs In ALK-Rearranged NSCLC

OncoDaily TV
STAMP Inhibitors Against CML: Prof. Timothy Hughes

STAMP Inhibitors Against CML: Prof. Timothy Hughes

Oncology's Greatest Threat: A System in Crisis

Oncology’s Greatest Threat: A System in Crisis

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

OncoDaily Grand Rounds at ASCO 2026: Sarcoma Edition: Highlights of the event

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

How Desmond Yip Helped Build Cancer Care in the Solomon Islands

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Gynecological Cancers, Cancer Vaccines & Immunotherapy: Are We Near Elimination?

Annalice Gandini

GI News Updates with Annalice Gandini

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Ringing the Bell Is Not the End of the Story, but the Beginning of a New One: Alejandra Méndez

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Episode 15: Global Health Dialogues with Princess Dina and Dr Garo Armen

Hisham Mehanna

What It Takes to Lead in Oncology Prof. Hisham Mehanna on Research, Mentorship & Life Balance

ASCO

ASCO 2026 with OncoDaily: Yvonne Awards, AI in Oncology, Grand Rounds and Live Coverage from Chicago

Lucica Ditiu

Ending Tuberculosis by 2030: Is It Still Possible? | Dr Lucica Ditiu

City-Level Cancer Care: A Missing Piece in the Puzzle?

City-Level Cancer Care: A Missing Piece in the Puzzle?

Not To Miss
ESMO TAT 2026- OncoDaily

15 Posts Not to Miss from ESMO TAT Asia 2026

25 Posts Not To Miss From EHA 2026, Part 3

25 Posts Not To Miss From EHA 2026, Part 2

25 Posts Not To Miss From EHA 2026

15 Posts Not To Miss From EACR 2026, Part 2

25 Posts Not To Miss From EACR 2026

Top Growing Medical Universities in Europe: 2026 Edition by BIGR

OncoGrants
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA

ACOG Foundation 2026 Request for Grant Proposals

ACOG Foundation 2026 Request for Grant Proposals

Clinical Trial Award — DoD OCRP

Clinical Trial Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Ovarian Cancer Academy – Early-Career Investigator Award — DoD OCRP

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Investigator-Initiated Research Award — DoD Ovarian Cancer Research Program

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Kids Beating Cancer — John Voight Memorial Leukemia Research Grant

Oncologist near me
Oncologist Near Me

Oncologist Near Me – Gregory Kalemkerian: Advancing Lung Cancer Care, Research, and Education
Oncologist Near Me

Oncologist Near Me – Nagashree Seetharamu: A Journey of Healing, Mentorship, and Leadership
Oncologist Near Me

Oncologist Near Me – Paolo Tarantino: Shaping the Future of Breast Cancer Treatment
Oncologist Near Me

Oncologist Near Me – Rana McKay: A Rising Force in Genitourinary Cancer Research and Care
Oncologist Near Me

Oncologist Near Me – Razelle Kurzrock: Revolutionizing Cancer Treatment Through Precision Medicine
Oncologist Near Me

Oncologist Near Me – Yelena Janjigian: A Global Leader in Gastrointestinal Oncology
Oncologist Near Me

Oncologist Near Me – Bishal Gyawali: Challenging the Status Quo in Global Oncology
Oncologist Near Me

Oncologist Near Me – Yan Leyfman: A Voice for Innovation, Mentorship, and Impact in Oncology
Oncologist Near Me

Oncologist Near Me – Wafik S. El-Deiry: A Global Leader in Translational Oncology and Cancer Research
Oncologist Near Me

Oncologist Near Me – Enrique Soto: A Leader in Geriatric Oncology and Global Cancer Care

Cancer types
BPDCN

Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN): Current Perspectives on an Ultra-Rare Malignancy

Richter Transformation (RT): When Chronic Lymphocytic Leukemia Turns Aggressive

Acute Myeloid Leukemia (AML) in 2026: The Current Landscape and Future Perspectives

Follicular Lymphoma (FL): From Evolving Biology to Modern Therapeutic Paradigms

Hodgkin Lymphoma (HL): Microenvironmental Biology Behind a Therapeutic Success Story

Colorectal Cancer: Epidemiology, Pathogenesis, Diagnosis, and Therapeutic Advances

Cholangiocarcinoma: Latest Risk Factors, Symptoms, Diagnosis, and 2025 Advanced Treatment Options for Bile Duct Cancer

CancerWorld

Oncologists
Wafik El-Deiry

Wafik El-Deiry

Oncologists Location Providence, USA
Jackson Orem

Jackson Orem

Oncologists Location Kampala, Uganda
Jean-Yves Blay

Jean-Yves Blay

Oncologists Location Lyon, France
Lynn Schuchter

Lynn Schuchter

Oncologists Location Philadelphia, USA
Vinod Balachandran

Vinod Balachandran

Oncologists Location New York, USA
Uddiptya Goswami

Uddiptya Goswami

Oncologists Location Thiruvananthapuram, India
Joyce Kambugu

Joyce Kambugu

Oncologists Location Kampala, Uganda
Khushali Jhaveri

Khushali Jhaveri

Oncologists Location Indianapolis, USA

Oncology Drugs
Sacituzumab Tirumotecan

Sacituzumab Tirumotecan: What Patients Should Know About This Emerging Cancer Treatment

Sacituzumab Tirumotecan: Clinical Development, Mechanism, and Emerging Role in Modern Oncology

Lurbinectedin: What Patients Should Know

Lurbinectedin in Oncology: Mechanism, Clinical Data, Evolving Role, and Future Directions

Bemarituzumab: What Patients with Gastric Cancer Should Know

Bemarituzumab: Uses in Cancer, Side Effects, Dosages, Expectations and More

GSK5764227 (HS-20093): A Novel B7-H3 Targeted Antibody–Drug Conjugate Under Clinical Investigation

OncoDaily Magazine

New Paper Alert
Screening - OncoDaily

A Unified Framework for Pre-Screening and Screening Tools in Oncology Clinical Trials 2026

Cardiovascular Disease

Prevention And Management Of Cardiovascular Disease In Adults With Cancer: IC-OS And MASCC Clinical Practice Statement

EORTC–ESTRO

Endpoints in Metastases Directed Therapy for Oligometastatic Cancer A Review and Consensus by the EORTC–ESTRO OligoCare Consortium

MONTBLANC Trial

MONTBLANC Trial Recruitment Completed: Triple Immunotherapy in Advanced HCC

Clinical Trial

How Clinicians Can Truly Understand Clinical Trial Results?

OrigAMI-1 Trial

OrigAMI-1 Trial: Amivantamab in Refractory Metastatic Colorectal Cancer

OncoDaily Medical Journal

Hematology

10.69690/ODMJ-001-0526-7344

Analysis of Mortality Factors in the Pediatric Hemato-Oncology Department of the Children's Hospital of Rabat, 2022-2023
Original Research

Radiation Oncology

10.69690/ODMJ-011-0526-7409

An Independent Read-Only Verification and Risk-Management System to Maintain Radiotherapy Safety During Oncology Information System Failure
Case Reports/Brief Reports

Cancer Care

10.69690/ODMJ-001-0426-7451

Distinct differences in the tumour-resident microbiome between early- and late-onset colorectal cancer
Original Research

Hematology

10.69690/odmj-012-0426-7512

Frailty, infections, and bispecific antibodies in multiple myeloma: redefining supportive care in the era of T-cell redirection
Commentaries

Oncology Nursing

10.69690/ODMJ-002-0426-7359

Barriers and Facilitators of Oral Nutritional Supplement Adherence in Cancer: A Systematic Review
Review

Hematology

10.69690/ODMJ-011-0426-7452

Double Dilemma: Managing a Sequential Lymphoma (Case Report)
Case Reports/Brief Reports

Hematology

10.69690/ODMJ-011-0426-7442

Outcome of Hematopoietic Stem Cell Transplantation in Pediatric Patients with Severe Aplastic Anemia and Multi-Drug Resistant Bacterial Infections - A Case Series
Case Reports/Brief Reports

Oncology Nursing

10.69690/ODMJ-001-0404-7332

Enhancing Palliative Care Through Simulation-Based Workshops for Effective Symptom Management
Original Research